Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Research priorities in sarcomeric cardiomyopathies.

Cardiovascular research - 1 Apr 2015

van der Velden Jolanda, Ho Carolyn Y, Tardiff Jil C, Olivotto Iacopo, Knollmann Bjorn C, Carrier Lucie

Abstract excerpt

The clinical variability in patients with sarcomeric cardiomyopathies is striking: a mutation causes cardiomyopathy in one individual, while the identical mutation is harmless in a family member. Moreover, the clinical phenotype varies ranging from asymmetric hypertrophy to severe dilatation of the heart. Identification of a single phenotype-associated disease mechanism would facilitate the design of targeted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research
Share to Cardiology
Share to Cardiomyopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genetic Predisposition to Disease

Share to Mutation

Share to Phenotype

Share to Sarcomeres

Source

Open in PubMed Open full text

Identifiers

PMID: 25631582
DOI: 10.1093/cvr/cvv019
PMCID: PMC4375392

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Research priorities in sarcomeric cardiomyopathies.PMID 25631582Read ↗

Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies.Semantic proximity Read ↗

From sarcomeric mutations to heart disease: understanding familial hypertrophic cardiomyopathy.Semantic proximity Read ↗

Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine.Semantic proximity Read ↗

Sarcomeric proteins and inherited cardiomyopathies.Semantic proximity Read ↗

Targets for therapy in sarcomeric cardiomyopathies.Semantic proximity Read ↗

Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.Semantic proximity Read ↗

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction.Semantic proximity Read ↗

Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Semantic proximity Read ↗

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy Beyond Sarcomere DysfunctionSemantic proximity Read ↗

A straightforward guide to the sarcomeric basis of cardiomyopathies.Semantic proximity Read ↗

Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Semantic proximity Read ↗

Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.